section name header

Evidence summaries

Dapsone as an Oral Corticosteroid Sparing Agent for Asthma

There is no evidence from randomized controlled trials of dapsone for steroid-dependent asthmatic patients. Level of evidence: "D"

A Cochrane review [Abstract] 1 found no trials that met the selection criteria. An update search conducted in February 2009 did not identify any new references for inclusion in the review.

References

  • Dewey A, Bara A, Dean T, Walters H. Dapsone as an oral corticosteroid sparing agent for asthma. Cochrane Database Syst Rev 2002;(4):CD003268 [Review content assessed as up-to-date: 12 February 2009]. [PubMed]

Primary/Secondary Keywords